Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.
Di LiangYuhua BaoMark WallaceIgor GrantYuyan ShiPublished in: Addiction (Abingdon, England) (2018)
State-wide medical cannabis legalization appears to have been associated with reductions in both prescriptions and dosages of Schedule III (but not Schedule II) opioids received by Medicaid enrollees in the United States.